$CAPR 4-bagger corrected. support $4.38


Website

Shares Outstanding: 11.70M
Float: 3.39M


10-Q 8/14/14




Press Releases

Wednesday, August 13, 2014
Capricor Therapeutics Reports Second Quarter 2014 Financial & Business HighlightsGlobeNewswire

Monday, August 4, 2014
Capricor Therapeutics to Hold Second Quarter 2014 Business Update Conference Call on August 13, 2014 at 4:30 p.m. Eastern TimeGlobeNewswire(

Wednesday, July 16, 2014
Capricor Announces Encouraging Results From Phase I ALLSTAR Trial; Phase II Trial UnderwayGlobeNewswire

Monday, June 23, 2014
Capricor Therapeutics to Present at the First Regenerative Medicine Forum at BIO International ConventionGlobeNewswire

Thursday, June 19, 2014
Capricor Therapeutics Speaks at Panel on Regulation of Stem Cell-Derived Therapeutic Products at DIA 2014 50th Annual MeetingGlobeNewswire

Friday, December 20, 2013
Capricor Therapeutics Announces Ticker Symbol Change to CAPRBusiness Wire

Tuesday, December 17, 2013
Capricor Therapeutics Cleared to Begin Phase II Portion of ALLSTAR Clinical Trial with CAP-1002 in Patients Following Heart AttackBusiness Wire

Thursday, November 21, 2013
Capricor and Nile Therapeutics Complete Merger to Form Capricor Therapeutics, Inc.Business Wire